These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2261696)

  • 1. Radioimmunoassay for plasma neuropeptide-Y in physiological and physiopathological states and response to sympathetic activation.
    Miller MA; Sagnella GA; Markandu ND; MacGregor GA
    Clin Chim Acta; 1990 Nov; 192(1):47-53. PubMed ID: 2261696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
    Morris MJ; Russell AE; Kapoor V; Cain MD; Elliott JM; West MJ; Wing LM; Chalmers JP
    J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.
    Leppert J; Nilsson H; Myrdal U; Edvinsson L; Hedner T; Ringqvist I
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):901-7. PubMed ID: 8011569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y and blood pressure in haemodialysis patients.
    Takahashi K; Mouri T; Tachibana Y; Itoi K; Sone M; Nozuki M; Murakami O; Ohneda M; Yoshinaga K
    Endocrinol Jpn; 1989 Aug; 36(4):553-8. PubMed ID: 2583063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia.
    Khatun S; Kanayama N; Belayet HM; Bhuiyan AB; Jahan S; Begum A; Kobayashi T; Terao T
    Am J Obstet Gynecol; 2000 Apr; 182(4):896-900. PubMed ID: 10764469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.
    Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD
    Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women.
    Egerman RS; Andersen RN; Manejwala FM; Sibai BM
    Am J Obstet Gynecol; 1999 Oct; 181(4):921-3. PubMed ID: 10521754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in plasma neuropeptide Y immunoreactivity and catecholamine levels during surgical removal of pheochromocytoma.
    Januszewicz W; Wocial B; Ignatowska-Switalska H; Dutkiewicz-Raczkowska M; Feltynowski T; Januszewicz A; Tapiński M; Zukowska-Grójec Z; Szostek M
    J Hypertens; 1998 Apr; 16(4):543-7. PubMed ID: 9797201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects.
    Chalmers J; Morris M; Kapoor V; Cain M; Elliott J; Russell A; Pilowsky P; Minson J; West M; Wing L
    Clin Exp Hypertens A; 1989; 11 Suppl 1():59-66. PubMed ID: 2743605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
    Mouri T; Sone M; Takahashi K; Itoi K; Totsune K; Hayashi Y; Hasegawa S; Ohneda M; Murakami O; Miura Y
    Clin Sci (Lond); 1992 Aug; 83(2):205-11. PubMed ID: 1327637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
    Feng QP; Hedner T; Andersson B; Lundberg JM; Waagstein F
    Br Heart J; 1994 Mar; 71(3):261-7. PubMed ID: 8142196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon.
    Leppert J; Myrdal U; Hedner T; Edvinsson L; Tracz Z; Ringqvist I
    Angiology; 1994 Jul; 45(7):637-45. PubMed ID: 8024163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig.
    Rudehill A; Olcén M; Sollevi A; Hamberger B; Lundberg JM
    Acta Physiol Scand; 1987 Dec; 131(4):517-23. PubMed ID: 3442241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat.
    Cheng JT; Chen CF; Shum AY; Wang JY; Chen HI
    Neurosci Lett; 1992 Jun; 140(2):211-4. PubMed ID: 1501780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes of exercise-induced plasma catecholamines and neuropeptide Y responses in normal human subjects.
    Winther Jensen E; Espersen K; Kanstrup IL; Christensen NJ
    Acta Physiol Scand; 1992 Feb; 144(2):129-33. PubMed ID: 1575046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy.
    Terelak-Borys B; Czechowicz-Janicka K
    Klin Oczna; 2011; 113(7-9):201-8. PubMed ID: 22256559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phentolamine- and clonidine-induced changes in plasma neuropeptide Y-like immunoreactivity during sympathetic activation in man.
    Pernow J; Lundberg JM; Kaijser L
    Clin Physiol; 1987 Oct; 7(5):431-4. PubMed ID: 2822340
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis.
    Kazzam E; Caidahl K; Hedner T; Hedner J; Waldenström A
    Scand J Rheumatol; 1999; 28(4):238-43. PubMed ID: 10503561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.
    Malmström RE; Lundberg JO; Weitzberg E
    Eur J Pharmacol; 2002 Mar; 439(1-3):113-9. PubMed ID: 11937100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.